Pakistan PPR study flags surveillance needs near protected areas
Bottom line
PPR antibodies were widespread in sheep and goats sampled near protected wildlife areas in Pakistan, according to a June 2024 study in Veterinary Sciences. In an exploratory cross-sectional survey conducted from January through June 2024, researchers tested 1,939 serum samples from 56 herds near eight protected areas and found evidence of substantial prior exposure or vaccination in both goats and sheep. The study included vaccinated and unvaccinated animals, and the competitive ELISA used cannot distinguish vaccine-derived antibodies from antibodies generated after natural infection, which means the results point to circulation or immunization pressure rather than active disease on their own. The work adds fresh data to a long-running concern in Pakistan: PPR remains endemic, and the livestock-wildlife interface is a recognized surveillance gap. (mdpi.com)
Why it matters: For veterinary professionals, the main takeaway is that seropositivity around protected areas should not be read as proof of current outbreak activity, but it does signal that these border zones between domestic flocks and wildlife deserve closer, more integrated surveillance. Pakistan has dealt with PPR for years, and prior work has already highlighted risk at the wildlife-livestock interface in Punjab. Globally, FAO and WOAH are still targeting PPR eradication by 2030, with surveillance, movement control, and targeted vaccination central to that strategy. For field veterinarians and animal health officials, this study reinforces the need to pair serology with outbreak investigation, vaccination history, and, where possible, molecular testing if they want to understand whether antibodies reflect protection, recent circulation, or both. (pmc.ncbi.nlm.nih.gov)
What to watch: Watch for follow-up work using virologic testing, more standardized vaccination histories, or wildlife sampling to clarify whether protected-area interfaces are acting mainly as spillover zones, persistence zones, or both. (oie.int)
Key facts
- Topic
- PPRV antibodies in sheep and goats near protected wildlife areas in Pakistan
- Study design
- Exploratory cross-sectional survey
- Study period
- January through June 2024
- Sample size
- 1,939 serum samples
- Herds sampled
- 56 herds
- Species sampled
- 1,327 goats and 612 sheep
- Sampling area
- Eight protected wildlife areas in Pakistan
- Main limitation
- Competitive ELISA cannot distinguish vaccine-derived antibodies from antibodies after natural infection
A new Pakistan study is adding current field data to one of small-ruminant medicine’s persistent questions: what does PPR exposure look like where domestic herds graze near wildlife habitat? In a paper published in Veterinary Sciences in June 2024, investigators reported PPRV antibody findings from 1,939 sheep and goats sampled in 56 herds around eight protected wildlife areas. Because the survey included both vaccinated and unvaccinated animals, and used a competitive ELISA that cannot separate vaccine-induced antibodies from those produced after infection, the study is best understood as a surveillance signal, not a direct measure of active transmission. (mdpi.com)
That distinction matters because PPR is already well established in Pakistan. Earlier reviews and epidemiologic studies describe the disease as endemic in the country, with repeated outbreaks, meaningful production losses, and ongoing concern about transmission where herds mix, move seasonally, or share pasture and water. Pakistan has also been part of broader regional and international PPR control efforts, as FAO and WOAH continue to push toward the global 2030 eradication target. (pmc.ncbi.nlm.nih.gov)
The new study builds on that history by focusing specifically on protected-area interfaces, a setting that can be difficult to interpret epidemiologically. Prior work from Punjab, including studies involving Muhammad Abubakar and collaborators, has already examined PPR risk factors at the wildlife-livestock interface and found evidence that these zones merit attention even when overt outbreak activity is not obvious. More broadly, WOAH-FAO guidance has emphasized that wildlife-livestock interfaces require tailored surveillance approaches during PPR control and eradication campaigns. (pubmed.ncbi.nlm.nih.gov)
What the paper appears to contribute, based on the abstract and publication record, is updated serologic evidence from January to June 2024 across a relatively large sample set: 1,327 goats and 612 sheep from purposively selected herds near eight protected wildlife areas. That sampling design makes the findings useful for identifying higher-interest zones, but it also limits how far the results can be generalized nationally. And because antibody testing alone cannot confirm active infection, the study should be read alongside Pakistan’s broader surveillance picture rather than as a stand-alone estimate of current disease burden. (mdpi.com)
There does seem to be a wider industry and research consensus on the bigger point: antibody detection near protected areas is important, but it is only one layer of evidence. Research from other wildlife-adjacent systems has suggested that wildlife may often function as spillover hosts rather than long-term maintenance hosts, with livestock presence near protected areas driving much of the exposure risk. Regional WOAH reporting has also highlighted the need for better studies on virus dynamics at the wildlife-livestock interface and for coordinated vaccination and surveillance across borders. (mdpi.com)
Why it matters: For veterinarians, especially those involved in herd health, field epidemiology, public veterinary services, or transboundary disease programs, this study is a reminder that serology has real value, but also real limits. A positive antibody signal in a vaccinated population can support risk mapping and program planning, yet it cannot answer the operational question clinicians and regulators often care about most: is virus circulating right now? In practice, that means surveillance near protected areas should combine serology with vaccination records, clinical reporting, movement history, and confirmatory virologic testing when disease is suspected. It also reinforces a One Health-style reality for mixed-use landscapes: livestock health planning near wildlife habitat is not just about outbreak response, but about routine monitoring, campaign design, and communication with producers. (oie.int)
For pet parents in the U.S., PPR is not a companion-animal disease story. But for veterinary professionals following global animal health, it is relevant because it shows how eradication efforts can stall without good surveillance at ecological edges, where domestic animal management, wildlife conservation, and animal movement all overlap. Those lessons often translate beyond one pathogen or one species. (woah.org)
What to watch: The next meaningful step would be follow-up studies that add PCR or virus detection, cleaner vaccination-status stratification, and ideally targeted wildlife surveillance, so officials can tell whether these protected-area zones are mainly reflecting successful immunization, recent field exposure, or ongoing transmission pressure as the 2030 eradication timeline approaches. (oie.int)
How this developed
-
Researchers began sampling sheep and goats near protected wildlife areas in Pakistan.
-
The study was published in Veterinary Sciences.
Common questions
What did the study find?
It found evidence of substantial prior exposure or vaccination in sheep and goats sampled near protected wildlife areas in Pakistan.Can this study tell whether PPR is actively circulating?
No. The antibody test used cannot separate vaccine-induced antibodies from antibodies caused by natural infection, so the results do not prove active disease on their own.Where were the animals sampled?
From herds near eight protected wildlife areas in Pakistan.Why does this matter for surveillance?
It suggests that protected-area border zones deserve closer, integrated surveillance, but serology should be paired with vaccination history and, when possible, molecular testing.